Abstract
SummaryThree hundred and sixty-nine Marine Corps recruits, initially without either complement fixing or toxin neutralizing epidemic typhus antibodies, were studied to determine their antibody response to subcutaneous injection of decreasing doses of commercially produced epidemic typhus vaccine administered in 1 or 2 doses of 1 ml each. When immunized with either 1 or 2 doses of undiluted vaccine or with 1 dose of vaccine diluted 1:2 or 1:4 91 to 100% of the 194 marines responded by developing either complement fixing or toxin neutralizing antibodies, or both. About 1/3 of 116 marines who received 1 dose of vaccine diluted 1:16 or 1:64 developed these antibodies. A single dose of vaccine diluted 1:256 elicited demonstrable antibodies in 15% or 9 of 59 men. These results suggested that the amount of antigen contained in 2.0 ml of vaccine required in the basic course of the immunization regimen was more than was needed to accomplish reasonable antibody responses in man. Accordingly, the primary immunizatio...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
